Hypertension Diagnostics (HDII) Stock Statistics & Valuation Metrics

Hypertension Diagnostics has a market cap or net worth of $285.00. The enterprise value is $13.68K.

Hypertension Diagnostics has 284,781,620 shares outstanding. The number of shares has decreased by -2.65% in one year.

Hypertension Diagnostics’s return on equity (ROE) is 0.76 and return on invested capital (ROIC) is 100.00%.

The current PE Ratio of Hypertension Diagnostics is ―. Hypertension Diagnostics’s PEG ratio is -0.06.

In the last 12 months, Hypertension Diagnostics had revenue of 0.00 and earned -93.25K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -11.00K and capital expenditures 0.00, giving a free cash flow of -11.00K billion.

Hypertension Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―

Hypertension Diagnostics upcoming earnings date is ―, ―.

Hypertension Diagnostics as a current ratio of 0.00, with Debt / Equity ratio of 0.00%

In the past 12 months, Hypertension Diagnostics has paid 0.00 in taxes.

Hypertension Diagnostics EV to EBITDA ratio is 12.05, with an EV/FCF ratio of -1.83.

Hypertension Diagnostics has $86.39K in cash and marketable securities with $651.32K in debt, giving a net cash position of -$564.93K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Hypertension Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―